Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes

NCT00564668 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart

Sponsor

Novo Nordisk A/S